Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 3, 2012, Pages 494-503

  Rizzari, Michael D ^a,b   Suszynski, Thomas M ^a   Gillingham, Kristen J ^a   Dunn, Ty B ^a   Ibrahim, Hassan N ^a   Payne, William D ^a   Chinnakotla, Srinath ^a   Finger, Erik B ^a   Sutherland, David E R ^a   Kandaswamy, Raja ^a   Najarian, John S ^a   Pruett, Timothy L ^a   Kukla, Aleksandra ^a   Spong, Richard ^a   Matas, Arthur J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOTRIMAZOLE; COTRIMOXAZOLE; CYCLOSPORIN; DAPSONE; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; AVASCULAR NECROSIS; CATARACT; CHRONIC GRAFT REJECTION; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FIBROSING ALVEOLITIS; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; REGISTER; SURVIVAL RATE;

ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MINNESOTA; PREDNISONE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84858028820     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.08630811     Document Type: Article

References (44)

1. Citterio F: Steroid side effects and their impact on transplantation outcome. Transplantation 72[Suppl]: S75-S80, 2001
2. Morris PJ, Chan L, French ME, Ting A: Low dose oral prednisolone in renal transplantation. Lancet 1: 525-527, 1982
3. Vanrenterghem YF, Claes K, Montagnino G, Fieuws S, Maes B, Villa M, Ponticelli C: Risk factors for cardiovascular events after successful renal transplantation. Transplantation 85: 209-216, 2008
4. Prasad GV, Nash MM, McFarlane PA, Zaltzman JS: Renal transplant recipient attitudes toward steroid use and steroid withdrawal. Clin Transplant 17: 135-139, 2003
5. Hricik DE, O'Toole MA, Schulak JA, Herson J: Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: A meta-analysis. J Am Soc Nephrol 4: 1300-1305, 1993
6. Kasiske BL, Chakkera HA, Louis TA, Ma JZ: A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 11: 1910-1917, 2000
7. Ahsan N, Hricik D, Matas A, Rose S, Tomlanovich S, Wilkinson A, Ewell M, McIntosh M, Stablein D, Hodge E; Steroid Withdrawal Study Group: Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil-a prospective randomized study. Transplantation 68: 1865-1874, 1999
8. Vanrenterghem Y, Lebranchu Y, Hené R, Oppenheimer F, Ekberg H: Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation 70: 1352-1359, 2000
9. Pascual J, Quereda C, Zamora J, Hernández D; SpanishGroup for Evidence-Based Medicine in Renal Transplantation: Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: A meta-analysis of randomized, controlled trials. Transplantation 78: 1548-1556, 2004
10. Luan FL, Steffick DE, Ojo AO: Steroid-free maintenance immunosuppression in kidney transplantation: Is it time to consider it as a standard therapy? Kidney Int 76: 825-830, 2009
11. Matas AJ: Minimization of steroids in kidney transplantation. Transpl Int 22: 38-48, 2009
12. Pascual J, Zamora J, Galeano C, Royuela A, Quereda C: Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev 1: CD005632, 2009
13. Schiff J, Cole EH: Renal transplantation with early steroid withdrawal. Pediatr Nephrol 24: 243-251, 2009
14. Knight SR, Morris PJ: Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis. Transplantation 89: 1-14, 2010
15. Luan FL, Steffick DE, Ojo AO: New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression. Transplantation 91: 334-341, 2011
16. Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van Veldhuisen P; Astellas Corticosteroid Withdrawal Study Group: A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 248: 564-577, 2008
17. Matas AJ, Kandaswamy R, Humar A, Payne WD, Dunn DL, Najarian JS, Gruessner RW, Gillingham KJ, McHugh LE, Sutherland DE: Long-term immunosuppression, without maintenance prednisone, after kidney transplantation. Ann Surg 240: 510-516, 2004
18. Humar A, Gillingham K, Kandaswamy R, Payne W, Matas A: Steroid avoidance regimens: A comparison of outcomes with maintenance steroids versus continued steroid avoidance in recipients having an acute rejection episode. Am J Transplant 7: 1948-1953, 2007
19. U.S. Department of Health and Human Services HRSA: 2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008, Rockville, MD, U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, 2009
20. Luan FL, Steffick DE, Gadegbeku C, Norman SP, Wolfe R, Ojo AO: Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression. Am J Transplant 9: 160-168, 2009
21. Boots JM, Christiaans MH, Van Duijnhoven EM, Van Suylen RJ, Van Hooff JP: Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: A pilot study. Transplantation 74: 1703-1709, 2002
22. Kumar MS, Heifets M, Moritz MJ, Saeed MI, Khan SM, Fyfe B, Sustento-Riodeca N, Daniel JN, Kumar A: Safety and efficacy of steroid withdrawal two days after kidney transplantation: Analysis of results at three years. Transplantation 81: 832-839, 2006
23. Montagnino G, Sandrini S, Iorio B, Schena FP, Carmellini M, Rigotti P, Cossu M, Altieri P, Salvadori M, Stefoni S, Corbetta G, Ponticelli C: A randomized exploratory trial of steroid avoidance in renal transplant patients treatedwith everolimus and low-dose cyclosporine. Nephrol Dial Transplant 23: 707-714, 2008
24. Matas AJ, Gillingham KJ, Payne WD, Najarian JS: The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 57: 857-859, 1994
25. Humar A, Hassoun A, Kandaswamy R, Payne WD, Sutherland DE, Matas AJ: Immunologic factors: The major risk for decreased long-term renal allograft survival. Transplantation 68: 1842-1846, 1999
26. Vítko S, Klinger M, Salmela K, Wlodarczyk Z, Tydèn G, Senatorski G, Ostrowski M, Fauchald P, Kokot F, Stefoni S, Perner F, Claesson K, Castagneto M, Heemann U, Carmellini M, Squifflet JP, Weber M, Segoloni G, Bäckman L, Sperschneider H, Krämer BK: Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/ mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: Results of the Atlas study. Transplantation 80: 1734-1741, 2005
27. Kandaswamy R, Melancon JK, Dunn T, Tan M, Casingal V, Humar A, Payne WD, Gruessner RW, Dunn DL, Najarian JS, Sutherland DE, Gillingham KJ, Matas AJ: A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients-an interim analysis. Am J Transplant 5: 1529-1536, 2005
28. Anil Kumar MS, Heifets M, Fyfe B, Saaed MI, Moritz MJ, Parikh MH, Kumar A: Comparison of steroid avoidance in tacrolimus/ mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy. Transplantation 80: 807-814, 2005
29. Gallon L, Perico N, Dimitrov BD, Winoto J, Remuzzi G, Leventhal J, Gaspari F, Kaufman D: Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. Am J Transplant 6: 1617-1623, 2006
30. Gallon LG, Winoto J, Chhabra D, Parker MA, Leventhal JR, Kaufman DB: Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: Tacrolimus/mycophenolate mofetil versus tacrolimus/ sirolimus. Transplantation 83: 1324-1329, 2007
31. Anil Kumar MS, Moritz MJ, Saaed MI, Heifets M, Sustento- Reodica N, Fyfe B, Kumar A: Avoidance of chronic steroid therapy in African American kidney transplant recipients monitored by surveillance biopsy: 1-year results. Am J Transplant 5: 1976-1985, 2005
32. Alloway RR, Alexander JW, Buell JF, Cardi M, First MR, Hanaway MJ, Munda R, Rogers CC, Roy-Chaudhury P, Susskind B, Trofe J, Woodle ES: African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. AmJ Transplant 5: 356-365, 2005
33. Haririan A, Sillix DH, Morawski K, El-Amm JM, Garnick J, Doshi MD, West MS, Gruber SA: Short-term experience with early steroid withdrawal in African-American renal transplant recipients. Am J Transplant 6: 2396-2402, 2006
34. Zeng X, El-Amm JM, Doshi MD, Singh A, Morawski K, Cincotta E, Losanoff JE, West MS, Gruber SA: Intermediate-term outcomes with early steroid withdrawal in African-American renal transplant recipients undergoing surveillance biopsy. Surgery 142: 538-544, 2007
35. Alloway RR, Hanaway MJ, Trofe J, Boardman R, Rogers CC, Hanaway MJ, Buell JF, Munda R, Alexander JW, Thomas MJ, Roy-Chaudhury P, Cardi M, Woodle ES: A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: The Cincinnati experience. Transplant Proc 37: 802-803, 2005
36. Khwaja K, Asolati M, Harmon JV, Melancon JK, Dunn TB, Gillingham KJ, Kandaswamy R, Humar A, Gruessner RW, Payne WD, Najarian JS, Dunn DL, Sutherland DE, Matas AJ: Rapid discontinuation of prednisone in higher-risk kidney transplant recipients. Transplantation 78: 1397-1399, 2004
37. Chavers BMCC, Gillingham KJ, Matas AJ: Pediatric kidney transplantation using a novel protocol of rapid (6-day) discontinuation of prednisone: 2-year results. Transplantation 88: 237-241, 2009
38. Birkeland SA, Larsen KE, Rohr N: Pediatric renal transplantation without steroids. Pediatr Nephrol 12: 87-92, 1998
39. Oberholzer J, John E, Lumpaopong A, Testa G, Sankary HN, Briars L, Kraft KA, Knight PS, Verghese P, Benedetti E: Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients. Pediatr Transplant 9: 456-463, 2005
40. Ibrahim H, Rogers T, Casingal V, Sturdevant M, Tan M, Humar A, Gillingham K, Matas A: Graft loss fromrecurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol. Transplantation 81: 214-219, 2006
41. Trofe J, Alloway R, Rogers C, Roy-Chaudhury P, Cardi M, Safdar S, Groene B, Buell J, Hanaway M, Thomas M, Alexander W, Munda R, Woodle ES: Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis. Transplant Proc 37: 817-818, 2005
42. Desai NM, Schnitzler M, Jendrisak MD, Brennan DC: Maintenance steroid therapy for kidney recipients-not ready for relegation. Am J Transplant 9: 1263-1264, 2009
43. Knight SR, Morris PJ: Steroid avoidance or withdrawal in renal transplantation. Transplantation 91: e25-e27, 2011
44. Augustine JJ, Hricik DE: Steroid withdrawal: Moving on to the next questions. Am J Transplant 9: 3-4, 2009